1. Xilio Therapeutics Appoints Daniel S. Lynch as Chair of Board of Directors

    Xilio Therapeutics Appoints Daniel S. Lynch as Chair of Board of Directors

    Xilio Therapeutics, a company developing potent, tumor-selective immunotherapies for patients with cancer, today announced that Daniel S. Lynch has been appointed Chair of the company’s Board of Directors...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content
  2. Topics Mentioned